MedPath

JAMP POSACONAZOLE

JAMP POSACONAZOLE

Approved
DIN Number

02530333

Drug Class

Human

Market Date

May 24, 2023

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02530333
AIG Number0152201001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC04 POSACONAZOLE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

POSACONAZOLEActive
Strength: 40 MG / ML
Monograph: POSACONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.